Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCATE: Hydroxyurea vs Observation in Sickle Cell Anemia
NCT01531387Phase 3Terminated
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- May 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by Cincinnati Children's Hospital Medical Center. Started May 2012; status: terminated.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT01531387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01531387.